Tag: M.W:200-300

Reference of 777-12-8, Chemistry can be defined as the study of matter and the changes it undergoes. You¡¯ll sometimes hear it called the central science because it is the connection between physics and all the other sciences, starting with biology.777-12-8, Name is 6-(Trifluoromethyl)benzo[d]thiazol-2-amine, molecular formula is C8H5F3N2S. In a patent, introducing its new discovery.

The invention relates to a family of differently substituted benzothiazoles having an inhibitory activity against the enzyme casein kinase 1 (CK1), as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmological diseases, as well as for inducing cell regeneration.

The invention relates to a family of differently substituted benzothiazoles having an inhibitory activity against the enzyme casein kinase 1 (CK1), as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmological diseases, as well as for inducing cell regeneration.

If you are interested in 777-12-8, you can contact me at any time and look forward to more communication.Reference of 777-12-8

Reference£º
Thiazole | C3H6693NS – PubChem,
Thiazole | chemical compound | Britannica

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.1187451-28-0, Name is (4-(Thiazol-2-yl)phenyl)methanamine hydrochloride, molecular formula is C10H11ClN2S. In a Patent£¬once mentioned of 1187451-28-0, SDS of cas: 1187451-28-0

The present invention is to provide a medical composition for the treatment or prophylaxis of glaucoma which comprises a pyridylaminoacetic acid compound represented by the formula (1): wherein R1, R2 and R3 each independently represent a hydrogen atom or C1-C6 alkyl group, Y represents a bicyclic heteroaromatic ring group which may be substituted by a group(s) selected from the group consisting of a halogen atom, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group, halogeno C1-C6 alkoxyl group and C1-C6 alkylthio group or a group -Q1-Q2 wherein Q1 represents an arylene group or 5- to 6-membered heteroarylene group, Q2 represents an aromatic group or a 5- to 6-membered ring heterocyclic group each of which may be substituted by a group(s) selected from the group consisting of a halogen atom, hydroxyl group, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group and halogeno C1-C6 alkoxyl group, Z represents an aromatic group or a 5- to 6-membered heteroaromatic ring group each of which may be substituted by a group(s) selected from the group consisting of a halogen atom, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group and halogeno C1-C6 alkoxyl group, or a pharmaceutically acceptable salt thereof as an effective ingredient.

The present invention is to provide a medical composition for the treatment or prophylaxis of glaucoma which comprises a pyridylaminoacetic acid compound represented by the formula (1): wherein R1, R2 and R3 each independently represent a hydrogen atom or C1-C6 alkyl group, Y represents a bicyclic heteroaromatic ring group which may be substituted by a group(s) selected from the group consisting of a halogen atom, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group, halogeno C1-C6 alkoxyl group and C1-C6 alkylthio group or a group -Q1-Q2 wherein Q1 represents an arylene group or 5- to 6-membered heteroarylene group, Q2 represents an aromatic group or a 5- to 6-membered ring heterocyclic group each of which may be substituted by a group(s) selected from the group consisting of a halogen atom, hydroxyl group, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group and halogeno C1-C6 alkoxyl group, Z represents an aromatic group or a 5- to 6-membered heteroaromatic ring group each of which may be substituted by a group(s) selected from the group consisting of a halogen atom, C1-C6 alkyl group, halogeno C1-C6 alkyl group, C1-C6 alkoxyl group and halogeno C1-C6 alkoxyl group, or a pharmaceutically acceptable salt thereof as an effective ingredient.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.SDS of cas: 1187451-28-0, you can also check out more blogs about1187451-28-0

Reference£º
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 51618-29-2, Name is 6-Chlorobenzo[d]thiazole-2-thiol, molecular formula is C7H4ClNS2. In a Article£¬once mentioned of 51618-29-2, category: thiazole

An unprecedented asymmetric desymmetrization of meso-epoxides, derived from cyclopentene-1,3-diones, with 2-mercaptobenzothiazoles has been realized. It was efficiently catalyzed by a chiral DyIII/N,N?-dioxide complex through a thiolysis/elimination sequence. This remote stereocontrol strategy provides facile access to synthetically versatile cyclopentene derivatives bearing an all-carbon quaternary stereogenic center in high yield and excellent enantioselectivity. Intriguingly, optically active thiophene could be readily generated from the obtained product through an efficient one-pot protocol. Cap it all: The title reaction of meso-diketoepoxides with 2-mercaptobenzothiazoles has been realized. An array of cyclopentene-1,3-diones bearing an all-carbon quaternary stereogenic center were obtained in high yield and excellent enantioselectivity. This methodology paves the way for the construction of optically active thiophenes.

An unprecedented asymmetric desymmetrization of meso-epoxides, derived from cyclopentene-1,3-diones, with 2-mercaptobenzothiazoles has been realized. It was efficiently catalyzed by a chiral DyIII/N,N?-dioxide complex through a thiolysis/elimination sequence. This remote stereocontrol strategy provides facile access to synthetically versatile cyclopentene derivatives bearing an all-carbon quaternary stereogenic center in high yield and excellent enantioselectivity. Intriguingly, optically active thiophene could be readily generated from the obtained product through an efficient one-pot protocol. Cap it all: The title reaction of meso-diketoepoxides with 2-mercaptobenzothiazoles has been realized. An array of cyclopentene-1,3-diones bearing an all-carbon quaternary stereogenic center were obtained in high yield and excellent enantioselectivity. This methodology paves the way for the construction of optically active thiophenes.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.category: thiazole. In my other articles, you can also check out more blogs about 51618-29-2

Reference£º
Thiazole | C3H7008NS – PubChem,
Thiazole | chemical compound | Britannica

In an article, published in an article, once mentioned the application of 2103-99-3, Name is 4-(4-Chlorophenyl)thiazol-2-amine,molecular formula is C9H7ClN2S, is a conventional compound. this article was the specific content is as follows.Computed Properties of C9H7ClN2S

In this work, 2-(4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio)-N- (thiazol-2-yl) acetamide derivatives were synthesized by reacting 4,5-dimethyl-1-(phenylamino)-1H-imidazole-2(3H)-thione derivatives with some 2-chloro-N-(thiazol-2-yl)acetamide compounds. The structure of synthesized compounds was confirmed by IR, 1H NMR, and mass spectra. Anticancer activities of the compounds selected by the National Cancer Institute were investigated by testing against a panel of 60 different human tumor cell lines derived from nine neoplastic cancer types. Compounds 7, 13, and 23 exhibited reasonable anticancer activity against the screened cancer types with relatively low GI50 values. The compounds showed high activity against melanoma-type cell lines.

In this work, 2-(4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio)-N- (thiazol-2-yl) acetamide derivatives were synthesized by reacting 4,5-dimethyl-1-(phenylamino)-1H-imidazole-2(3H)-thione derivatives with some 2-chloro-N-(thiazol-2-yl)acetamide compounds. The structure of synthesized compounds was confirmed by IR, 1H NMR, and mass spectra. Anticancer activities of the compounds selected by the National Cancer Institute were investigated by testing against a panel of 60 different human tumor cell lines derived from nine neoplastic cancer types. Compounds 7, 13, and 23 exhibited reasonable anticancer activity against the screened cancer types with relatively low GI50 values. The compounds showed high activity against melanoma-type cell lines.

Do you like my blog? If you like, you can also browse other articles about this kind. Computed Properties of C9H7ClN2S. Thanks for taking the time to read the blog about 2103-99-3

Reference£º
Thiazole | C3H10197NS – PubChem,
Thiazole | chemical compound | Britannica

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.29182-42-1, Name is Ethyl 2-(benzo[d]thiazol-2-yl)acetate, molecular formula is C11H11NO2S. In a Article£¬once mentioned of 29182-42-1, Application In Synthesis of Ethyl 2-(benzo[d]thiazol-2-yl)acetate

The adducts of Meldrum’s acid and activated methyleneazoles with 4,5-dichloro-1,2,3-dithiazolium chloride are described.Some of these adducts display an interesting equilibrium between two stereoisomers, which have either a S…O or a S…N interaction.

The adducts of Meldrum’s acid and activated methyleneazoles with 4,5-dichloro-1,2,3-dithiazolium chloride are described.Some of these adducts display an interesting equilibrium between two stereoisomers, which have either a S…O or a S…N interaction.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Application In Synthesis of Ethyl 2-(benzo[d]thiazol-2-yl)acetate, you can also check out more blogs about29182-42-1

Reference£º
Thiazole | C3H7838NS – PubChem,
Thiazole | chemical compound | Britannica

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.5304-21-2, Name is 6-Bromo-2-methylbenzo[d]thiazole, molecular formula is C8H6BrNS. In a Article£¬once mentioned of 5304-21-2, category: thiazole

The title compound, C34H40N2O2S2, adopts a trans conformation. The four conjugated Csp2-Csp2 single and double bonds of the polymethinic moiety, which bridges both heterocyclic end groups and the central four-membered ring, display nearly equal bond lengths. The molecule is nearly planar, with interplanar angles between the benzothiazole end groups and the central four-membered ring of 6.9 (1) and 7.7 (1); the angle between the heterocyclic systems is 1.8 (1). The crystal packing involves pi-stacking effects, with intermolecular C¡¤¡¤¡¤C distances varying from 3.755 (3) to 3.991 (3) angstroms.

The title compound, C34H40N2O2S2, adopts a trans conformation. The four conjugated Csp2-Csp2 single and double bonds of the polymethinic moiety, which bridges both heterocyclic end groups and the central four-membered ring, display nearly equal bond lengths. The molecule is nearly planar, with interplanar angles between the benzothiazole end groups and the central four-membered ring of 6.9 (1) and 7.7 (1); the angle between the heterocyclic systems is 1.8 (1). The crystal packing involves pi-stacking effects, with intermolecular C¡¤¡¤¡¤C distances varying from 3.755 (3) to 3.991 (3) angstroms.

The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.I hope my blog about 5304-21-2 is helpful to your research., category: thiazole

Reference£º
Thiazole | C3H6795NS – PubChem,
Thiazole | chemical compound | Britannica

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.39736-29-3, Name is Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate, molecular formula is C7H10N2O2S2. In a Article£¬once mentioned of 39736-29-3, Application In Synthesis of Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate

A variety of partly novel tri- and tetracyclic hetero systems were obtained by reaction of heteroaromatic 2-aminoesters with 2-(methylthio)-2-thiazoline, yielding double-annelation of a thiazolo[2,3-b]pyrimido moiety in a one-pot process.

A variety of partly novel tri- and tetracyclic hetero systems were obtained by reaction of heteroaromatic 2-aminoesters with 2-(methylthio)-2-thiazoline, yielding double-annelation of a thiazolo[2,3-b]pyrimido moiety in a one-pot process.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Application In Synthesis of Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate, you can also check out more blogs about39736-29-3

Reference£º
Thiazole | C3H8240NS – PubChem,
Thiazole | chemical compound | Britannica

Children learn through play, and they learn more than adults might expect. Science experiments are a great way to spark their curiosity, get their minds active, and encourage them to do something that doesn¡¯t involve a screen. 66947-92-0, C9H8N2O2S. A document type is Patent, introducing its new discovery., SDS of cas: 66947-92-0

The invention provides compounds of formula (1 ) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of AIk, AbI, Aurora-A, B-Raf, Bcr-Abl, BRK, BIk, Bmx, c-Kit, c-RAF, cSRC. CSK, FLTl, Fms, Fyn, JAK2, KDR, Lck, Lyn, PDGFRalpha, PDGFRbeta, PKCalpha, p38 (p38 MAP kinase, SAPK2alpha), Src, SIK, Syk, Tie2 and TrkB kinases

The invention provides compounds of formula (1 ) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of AIk, AbI, Aurora-A, B-Raf, Bcr-Abl, BRK, BIk, Bmx, c-Kit, c-RAF, cSRC. CSK, FLTl, Fms, Fyn, JAK2, KDR, Lck, Lyn, PDGFRalpha, PDGFRbeta, PKCalpha, p38 (p38 MAP kinase, SAPK2alpha), Src, SIK, Syk, Tie2 and TrkB kinases

Interested yet? Keep reading other articles of 66947-92-0!, SDS of cas: 66947-92-0

Reference£º
Thiazole | C3H8386NS – PubChem,
Thiazole | chemical compound | Britannica

In an article, published in an article, once mentioned the application of 39736-29-3, Name is Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate,molecular formula is C7H10N2O2S2, is a conventional compound. this article was the specific content is as follows.Recommanded Product: Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate

The present invention is for the anti-inflammatory compounds that have an inhibitory activity against protein tyrosine kinases and their pharmaceutical composition(s) containing the compound as the active ingredient. Since the compounds of the present invention can inhibit multiple protein kinases associated with inflammatory diseases and immune disorders, they are useful for their prevention or treatment.

The present invention is for the anti-inflammatory compounds that have an inhibitory activity against protein tyrosine kinases and their pharmaceutical composition(s) containing the compound as the active ingredient. Since the compounds of the present invention can inhibit multiple protein kinases associated with inflammatory diseases and immune disorders, they are useful for their prevention or treatment.

Do you like my blog? If you like, you can also browse other articles about this kind. Recommanded Product: Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate. Thanks for taking the time to read the blog about 39736-29-3

Reference£º
Thiazole | C3H8228NS – PubChem,
Thiazole | chemical compound | Britannica

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 161797-99-5, Name is Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate, molecular formula is C13H13NO3S. In a Patent£¬once mentioned of 161797-99-5, Formula: C13H13NO3S

The present invention provides a high-purity 2 – (3 – aldehyde – 4 – isobuoxy phenyl) – 4 – methyl thiazole – 5 – carboxylic acid ethyl ester, cyano phenol, sulfur on behalf of the acetamide as the starting material, merabilite acylation reaction 4 – hydroxy benzamide (II), the reaction product does not separation directly saisai zuo reaction, is separated to obtain 2 – (4 – hydroxy-phenyl) – 4 – methyl – 5 – thiazole carboxylic acid ethyl ester (III); of formula (III) acetate acylation reaction to the compound 2 – (3 – a aldehyde group – 4 – hydroxy-phenyl) – 4 – methyl – 5 – thiazole carboxylic acid ethyl ester (IV), the reaction product does not separation directly isobutyl reaction, formula (I) of 2 – (3 – aldehyde – 4 – isobuoxy phenyl) – 4 – methyl thiazole – 5 – carboxylic acid ethyl ester product, purity ? 99%, content ? 99%. The present invention production process is optimized, thereby greatly improving the quality of the products, and the yield is high. (by machine translation)

The present invention provides a high-purity 2 – (3 – aldehyde – 4 – isobuoxy phenyl) – 4 – methyl thiazole – 5 – carboxylic acid ethyl ester, cyano phenol, sulfur on behalf of the acetamide as the starting material, merabilite acylation reaction 4 – hydroxy benzamide (II), the reaction product does not separation directly saisai zuo reaction, is separated to obtain 2 – (4 – hydroxy-phenyl) – 4 – methyl – 5 – thiazole carboxylic acid ethyl ester (III); of formula (III) acetate acylation reaction to the compound 2 – (3 – a aldehyde group – 4 – hydroxy-phenyl) – 4 – methyl – 5 – thiazole carboxylic acid ethyl ester (IV), the reaction product does not separation directly isobutyl reaction, formula (I) of 2 – (3 – aldehyde – 4 – isobuoxy phenyl) – 4 – methyl thiazole – 5 – carboxylic acid ethyl ester product, purity ? 99%, content ? 99%. The present invention production process is optimized, thereby greatly improving the quality of the products, and the yield is high. (by machine translation)

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data.Formula: C13H13NO3S, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 161797-99-5, in my other articles.

Reference£º
Thiazole | C3H7790NS – PubChem,
Thiazole | chemical compound | Britannica